Portage Biotech Inc. Files 6-K Report
Ticker: ATON · Form: 6-K · Filed: Dec 12, 2024 · CIK: 1095435
| Field | Detail |
|---|---|
| Company | Portage Biotech INC. (ATON) |
| Form Type | 6-K |
| Filed Date | Dec 12, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: reporting, corporate-info, foreign-issuer
TL;DR
Portage Biotech Inc. filed a 6-K, confirming its foreign private issuer status and previous name changes.
AI Summary
Portage Biotech Inc. filed a Form 6-K on December 12, 2024, reporting as a foreign private issuer. The company, incorporated in the British Virgin Islands, previously operated under the names BONTAN CORP INC and DEALCHECK COM INC. Its principal executive office is located in Tortola, British Virgin Islands.
Why It Matters
This filing indicates ongoing reporting requirements for Portage Biotech Inc. as a foreign private issuer, providing transparency to investors about its corporate status and history.
Risk Assessment
Risk Level: low — This is a routine filing confirming corporate information and is not indicative of new risks.
Key Numbers
- 001-40086 — SEC File Number (Identifies the company's filing history with the SEC)
- 20241212 — Filing Date (Date the report was submitted to the SEC)
Key Players & Entities
- Portage Biotech Inc. (company) — Filer of the report
- BONTAN CORP INC (company) — Former company name
- DEALCHECK COM INC (company) — Former company name
- British Virgin Islands (location) — Jurisdiction of incorporation
- Ian Walters (person) — Company Contact Person
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, used to furnish information that the registrant makes or is required to make public in its home country, files or is required to file with a stock exchange, or distributes or is required to distribute to its security holders.
What are the previous names of Portage Biotech Inc. mentioned in the filing?
The filing states that Portage Biotech Inc. was formerly known as BONTAN CORP INC (name change date: 20030421) and DEALCHECK COM INC (name change date: 19990921).
Where is Portage Biotech Inc.'s principal executive office located?
The principal executive office of Portage Biotech Inc. is located at Clarence Thomas Building, P.O. Box 4649, Road Town, Tortola, British Virgin Islands, VG1110.
What is the company's SEC File Number?
The SEC File Number for Portage Biotech Inc. is 001-40086.
Who is the designated company contact person and their contact information?
The company contact person is Ian Walters, with a telephone number of 203.221.7378, and their address is c/o Portage Development Services Inc., 59 Wilton Road, Westport, Connecticut 06880.
Filing Stats: 319 words · 1 min read · ~1 pages · Grade level 10.9 · Accepted 2024-12-12 16:30:27
Filing Documents
- f6k_121224.htm (6-K) — 6KB
- exh_991.htm (EX-99.1) — 7KB
- 0001171843-24-006910.txt ( ) — 15KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Portage Biotech Inc. (Registrant) Date: December 12, 2024 /s/ Andrea Park Andrea Park Chief Financial Officer